Medical Subject Headings

Last uploaded: March 22, 2026

Id	http://purl.bioontology.org/ontology/MESH/C493743 http://purl.bioontology.org/ontology/MESH/C493743
Preferred Name	lorukafusp alfa
Synonyms	HU 14.18IL2 EMD 273063 antibody, human APN301 hu14.18-IL2 EMD 273063 EMD-273063 APN-301
Type	http://www.w3.org/2002/07/owl#Class

altLabel	HU 14.18IL2 EMD 273063 antibody, human APN301 hu14.18-IL2 EMD 273063 EMD-273063 APN-301 See more See less
prefLabel	lorukafusp alfa
Scope Statement	induced immune activation and was associated with reversible clinical toxicities at the MTD of 7.5 mg/m2/d in melanoma patients
type	http://www.w3.org/2002/07/owl#Class
tui	T116 T129 T121
HM	D007376 D000911
SC	1
TERMUI	T816630 T000966238 T000966239 T622455 T000966241 T000966240 T622454 T000966236 See more See less
TH	NLM (2004) NLM (2020) NLM (2012) INN (19XX)
SRC	J Clin Oncol. 2004 Nov 15;22(22):4463-73
MMR	20191031
notation	C493743
Semantic type UMLS property	http://purl.bioontology.org/ontology/STY/T129 http://purl.bioontology.org/ontology/STY/T121 http://purl.bioontology.org/ontology/STY/T116
cui	C5207020 C4759782 C5139716 C1529682
MeSH Frequency	18
DSC	20041207
Inverse of RB	PL21OR4LXE
Mapped to	http://purl.bioontology.org/ontology/MESH/D000911 http://purl.bioontology.org/ontology/MESH/D007376
MDA	20041207

Delete	Subject	Author	Type	Created
No notes to display